Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase EARLY_PHASE1 1

Status

Recruiting 2Active not recruiting 2

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 4Genitourinary 1

Conditions

Breast Neoplasms 3Triple Negative Breast Neoplasms 1

Interventions

Paclitaxel 162Fulvestrant 157Trastuzumab 156pembrolizumab 146Letrozole 137Carboplatin 118pertuzumab 104Capecitabine 104Specimen Handling 102Cyclophosphamide 102Anastrozole 90palbociclib 86abemaciclib 82Magnetic Resonance Spectroscopy 81exemestane 76Docetaxel 76Tamoxifen 75ribociclib 74trastuzumab deruxtecan 68Radiotherapy 62Biopsy 59Surveys and Questionnaires 55Gemcitabine 53130-nm albumin-bound paclitaxel 53olaparib 52sacituzumab govitecan 51Blood Specimen Collection 51Standard of Care 49Taxes 48eribulin 47

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Technetium Tc 99m Sestamibi × Breast × 1 year × Clear all
NCT02744053 2026-04-21

DCE-MRI and MBI in Assessing Tumor Response to Chemotherapy in Patients With Triple Negative Breast Cancer

M.D. Anderson Cancer Center

Phase EARLY_PHASE1 Active not recruiting
96 enrolled
Breast

Triple Negative Breast Neoplasms

NCT05042687 2026-04-15

Comparative Performance of Molecular Breast Imaging (MBI) to Magnetic Resonance Imaging (MRI) of the Breast in Identifying and Excluding Breast Carcinoma in Women at High Risk for Breast Cancer

M.D. Anderson Cancer Center

Phase NA Recruiting
300 enrolled
Breast

Breast Neoplasms

NCT02324387 2026-03-09

Tc99m Sestamibi Molecular Breast Imaging

M.D. Anderson Cancer Center

Phase NA Active not recruiting
96 enrolled
Breast

Breast Neoplasms

NCT06058650 2025-09-30

Molecular Breast Imaging Guidance for Breast Biopsy for Patients With Breast Abnormalities

Mayo Clinic

Phase NA Recruiting
70 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡